EU Innovation Network Core profile within the network

An agency of the European Union

EU Innovation Network Membership New NCAs* from September 2016 to date The Czech Republic – October 2016 Germany (BfArM) – October 2016 Denmark – November 2016 Target: All Human Medicines NCAs Following Adoption of mandate in September 2016

from 28 MSs

22 NCAs

Norway – March 2017 Estonia – April 2017 Poland – April 2017 Croatia – May 2017

Pre-Adoption of mandate Sept 2016 15 NCAs

* Please note that changes to appointed EU-IN members representing NCAs Innovation Offices are not highlighted here. 1

EU Innovation Network - Core profile within the network

EU Innovation Network Membership

2

AT

FI

FR

PT

SE

BE

EU

HR

PL

UK

CZ

ES

HU

NO

DE (BfArM)

EE

IE

NL

DE (PEI)

DK

IT

MT

EU Innovation Network - Core profile within the network

Core profile within the network Target products Chemical medicines (90%)

The EU Innovation offices Network focuses on HUMAN health products.

Biological medicines (95%)

Vaccines (85%)

ATMPs (90%)

Innovation offices welcome a large variety of health products provided they contain some innovative features (scientific, technological or therapeutics)

Generic medicines (80%)

Biosimilar medicines (70%)

Combined/borderline (95%)

Medical devices are addressed in 50% of the offices and will be made soon eligible in one additional office. One office works also on cosmetics.

Medical devices (50%) Innovative methods and tools for drug development (70%)

3

EU Innovation Network - Core profile within the network

Core profile within the network Target products

Target groups

Chemical medicines (92%)

Academic research laboratories (100%)

Biological medicines (100%)

Hospital units (100%)

Vaccines (83%)

Start-ups (100%)

ATMPs (92%)

SMEs (100%)

Generic medicines (75%)

National/International groups (85%)

Biosimilar medicines (75%)

Consortia (65%)

Combined/borderline (92%)

Consulting groups (65%)

Medical devices (50%) Innovative methods and tools for drug development (75%)

4

EU Innovation Network - Core profile within the network

The services of the Innovation Support Offices are directed to hospitals, academic groups and SMEs, research foundations, consortia. Some have also expressed their willingness to hear from Patient interest groups and or funding/networking organisations.

Core profile within the network

5

Target products

Target groups

Focus

Chemical medicines (92%)

Academic research laboratories (100%)

Quality/viral safety (100%)

Biological medicines (100%)

Hospital units (100%)

Preclinical (100%)

Vaccines (83%)

Start-ups (100%%)

Clinical (100%)

ATMPs (92%)

SMEs (100%)

Production process (90%)

Generic medicines (75%)

National/International groups (100%)

Pharmacovigilance (80%)

Biosimilar medicines (75%)

Consortia (67%)

Help to make the redaction of documents (25%)

Combined/borderline (92%)

Consulting groups (67%)

Import / export (55%)

Medical devices (50%)

Regulatory processes (100%)

Innovative methods and tools for drug development (75%)

HTA/reimbursement – Payers (40%)

EU Innovation Network - Core profile within the network

The scope is wide and includes along the lifecycle of products manufacturing processes, redaction of documents, facilities, GMP, import/export issues, antimicrobials, biostatistics, preparations for scientific advice meetings, Pharmacovigilance, and HTA/Payers interactions

Core profile within the network

6

Target products

Target groups

Focus

Chemical medicines (90%)

Academic research laboratories (100%)

Quality/viral safety (100%)

Direct answer for simple questions (95%)

Biological medicines (95%)

Hospital units (100%)

Preclinical (100%)

Orientation towards the right competencies inside the Agency (90%)

Vaccines (85%)

Start-ups (100%%)

Clinical (100%)

Meeting for most innovative projects (70%)

ATMPs (90%)

SMEs (100%)

Production process (90%)

Diffusion of information via newsletter (15%)

Generic medicines (80%)

National/International groups (85%)

Pharmacovigilance (80%)

Diffusion of information via website (60%)

Biosimilar medicines (70%)

Consortia (65%)

Help to make the redaction of documents (25%)

Diffusion of information via organisation of meetings on specific topics (50%)

Combined/borderline (95%)

Consulting groups (65%)

Importation / exportation (55%)

Medical devices (50%)

Regulatory processes (100%)

Innovative methods and tools for drug development (70%)

Economic HTA/reimbursement – Payers (40%)

EU Innovation Network - Core profile within the network

Services

Diffusion of information via participation to meetings about health innovation (75%)

Identification of the core profile should allow the network to…

Ensure seamless support at national and EU level Prepare the EMRN for successful support to priority medicines

Develop EU methodology for innovation horizon scanning

Develop new ways to better communicate with target groups 7

EU Innovation Network - Core profile within the network

Encourage lifescience innovation for methods and tools for drug development

Identify challenging issues from emerging innovation

Identify best expertise

Develop training

Thank you for your attention Further information Heads of Medicines Agencies www.hma.eu European Medicines Agency www.ema.europa.eu

EU Innovation Network - Core profile within the network - European ...

1. EU Innovation Network Membership. Pre-Adoption of mandate Sept. 2016 ... The EU Innovation offices Network focuses on ... The services of the Innovation.

247KB Sizes 25 Downloads 262 Views

Recommend Documents

EU Innovation Network - European Medicines Agency - Europa EU
New NCAs* from September 2016 to date. The Czech Republic – October 2016. Germany (BfArM) – October 2016. Denmark – November 2016. Norway ...

EU Innovation Network - European Medicines Agency - Europa EU
European Medicines Agency www.ema.europa.eu. EU Innovation Offices Network. E-mail addresses for users. Contact: [email protected].

EU Innovation Network leaflet - Innovators meet regulators - European ...
Poland. Urząd Rejestracji Produktów Leczniczych, Wyrobow Medycznych i Produktów Biobójczych. [email protected]. Portugal. Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. (INFARMED) [email protected]. Finland. Lääkealan turval

Mandate of the European Innovation Network - European Medicines ...
Sep 30, 2016 - the EU supportive tools, especially scientific advice and PRIME schema. ... Discuss best practices so that the EU network builds on success and encourages ... referred to the HMA management group and EMA for approval.

Aggressive Synchronous Transmissions withIN-network ...
niques to enhance the robustness of synchronous flooding while keeping the latency and power consumption minimal and how to collect data from multiple sources to multiple destinations. 1 Introduction. Dependable low-power wireless protocols are a key

European network of paediatric research at the European Medicines ...
however, only networks of category 1-4 that updated the forms regularly are ... good practice as well as a list of ideal services that networks can provide was ...

European network of paediatric research at the European Medicines ...
Arch Dis Child Published Online. First:25 May ... benefit from additional training in the following areas: IT training / clinical trial setup / specialist skills for clinical ...

European network of paediatric research at the European Medicines ...
This new working group, co-chaired by a PDCO member and the representative of a national multi- disciplinary network, had its 1st face to ... decision tree, (d) risk management strategy. We thank the members of all ... We wish you and your families M

Sticky-Church-Leadership-Network-Innovation-Series.pdf ...
There was a problem loading more pages. Retrying... Whoops! There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. Sticky-Church-Leadership-Network-Innovation-Seri

European Union Network data board - European Medicines Agency
Sep 21, 2016 - EMA/231985/2016. European Union Network Data Board. Terms of Reference. 1. Remit, vision and mission. The European Union Network Data Board (EUNDB) is an advisory body co-chaired by the Head of. Business Data and Support Department (EM

Minutes of the European network of paediatric research at the ...
Nov 10, 2016 - Thursday 06 October 2016, EMA room 03-K and via Adobe Connect;. 13.00 to 15.20 UK .... paediatric specific training for Ethics. Committees ...

Minutes of the European network of paediatric research at the ...
Nov 10, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Human Medicines Research & Development Support Division. Minutes .... networks to share best practices, funding models, organizational ...

2017 Annual workshop of the European network of paediatric
May 15, 2017 - malignancy under the age of 3 years: TBI is what really matters, Bone ..... primary care research network, but there is no formal affiliation.

Coordinating group of European network of paediatric research at the ...
Sep 9, 2016 - National Institute for Health. Research Clinical Research ... Anne Junker [email protected]. Duke Clinical Research Institute. Brian Smith.

The European Union regulatory network incident management plan ...
necessary legal tools to allow for such monitoring, hence contributing to the safe .... The Pharmacovigilance Rapid Alert (RA) and Non-Urgent Information (NUI) ...

2017 Annual workshop of the European network of paediatric
May 15, 2017 - Analysis on Behalf of the Pediatric Disease Working Party of the .... participating researchers for analysis of clinical and biobank data once.

EU ACC3 - European Commission - Europa EU
As a shipper, freight forwarder, screening facility, ground handler or postal operator you may handle cargo or mail relevant to this programme. Is your company.

Checklist for prioritisation of EU regulatory network collaborative ...
Jun 20, 2017 - taking into account the size of the affected population across .... behaviour, to change the way the product is used in clinical practice or to.

Checklist for prioritisation of EU regulatory network collaborative ...
Jun 20, 2017 - A key deliverable of the Pharmacovigilance Risk Assessment ... the generation of data to monitor impact of regulatory interventions in public .... big is the population using the product in the EU taking into account exposure.

[Fei Hu]Network Innovation through OpenFlow and SDN Principles ...
Page 1 of 517. Page 1 of 517 ..... [Fei Hu]Network Innovation through OpenFlow and SDN Principles and Design(pdf){Zzzzz}.pdf. [Fei Hu]Network Innovation ...

The CETA Agreement - European Commission - Europa EU
Regarding wine and spirits CETA also: • abolishes the Canadian requirement to blend imported bulk spirits with local spirits before bottling – a requirement that made it impossible for EU makers of products classified as Geographical. Indications

1 - 200509 - Trans European Transport Network (ten-t)_ ...
Connect more apps... Try one of the apps below to open or edit this item. 1 - 200509 - Trans European Transport Network (ten-t)_pp_axes_projects_2005.pdf.

1 - 200509 - Trans European Transport Network (ten-t)_ ...
Page 1. Whoops! There was a problem loading more pages. Retrying... 1 - 200509 - Trans European Transport Network (ten-t)_pp_axes_projects_2005.pdf.

Endophenotype Network Models: Common Core of ...
SCIENTIFIC REPORTS | 6:27414 | DOI: 10.1038/srep27414 www.nature.com/ ... Physics, Budapest University of Technology and Economics, Budapest, Hungary. 4Division of ... 8University Heart Center Hamburg, Clinic for General and .... of preclinical disea